Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Imdevimab Emergency use authorization Experimental Antiviral Mar/20/2021 2 0
Casirivimab Emergency use authorization Experimental Antiviral Mar/20/2021 2 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Mar/19/2021 23 7
Remdesivir Approved by FDA Experimental Antiviral Mar/05/2021 60 4
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 15
hrsACE2 Potential treatment - pre-clinical evidence Experimental Antiviral Nov/12/2020 1 0
Fluvoxamine Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/12/2020 1 0
Acarbose Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/12/2020 3 0
Hyaluronic acid Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/12/2020 2 0